Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: Implications for graft engineering

Experimental Hematology

Volumn 34, Issue 6, 2006, Pages 788-795

  Scheinberg, Phillip ^a   Price, David A ^b   Ambrozak, David R ^b   Barrett, A John ^a   Douek, Daniel C ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; INTERLEUKIN 2 RECEPTOR ALPHA; OLIGOCLONAL BAND; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COCULTURE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; GENE SEQUENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, SURFACE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COCULTURE TECHNIQUES; GENES, T-CELL RECEPTOR BETA; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MODELS, IMMUNOLOGICAL; TISSUE DONORS; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646707086     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.03.001     Document Type: Article

References (28)

1. Bach F.H., and Voynow N.K. One-way stimulation in mixed leukocyte cultures. Science 153 (1966) 545
2. Michalek J., Collins R.H., Hill B.J., Brenchley J.M., and Douek D.C. Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation. Lancet 361 (2003) 1183
3. Chao N.J. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease. Biol Blood Marrow Transplant 10 (2004) 215
4. Falkenburg J.H., Marijt W.A., Heemskerk M.H., and Willemze R. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions. Curr Opin Hematol 9 (2002) 497
5. Perreault C., Roy D.C., and Fortin C. Immunodominant minor histocompatibility antigens: the major ones. Immunol Today 19 (1998) 69
6. Sherman L.A., and Chattopadhyay S. The molecular basis of allorecognition. Annu Rev Immunol 11 (1993) 385
7. Wang X.N., Taylor P.R., Skinner R., et al. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Transplantation 70 (2000) 488
8. Bishara A., Brautbar C., Nagler A., et al. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation 57 (1994) 1474
9. Nguyen X.D., Eichler H., Dugrillon A., Piechaczek C., Braun M., and Kluter H. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 275 (2003) 57
10. Krieg A.M. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr Oncol Rep 6 (2004) 88
11. Solomon S.R., Tran T., Carter C.S., et al. Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation. Cytotherapy 4 (2002) 395
12. Douek D.C., Betts M.R., Brenchley J.M., et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 168 (2002) 3099
13. Price D.A., West S.M., Betts M.R., et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21 (2004) 793
14. Fehse B., Frerk O., Goldmann M., Bulduk M., and Zander A.R. Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69). Br J Haematol 109 (2000) 644
15. Koh M.B., Prentice H.G., and Lowdell M.W. Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. Bone Marrow Transplant 23 (1999) 1071
16. van Dijk A.M., Kessler F.L., Stadhouders-Keet S.A., Verdonck L.F., de Gast G.C., and Otten H.G. Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease. Br J Haematol 107 (1999) 169
17. Goulmy E., Schipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334 (1996) 281
18. Mutis T., Gillespie G., Schrama E., Falkenburg J.H., Moss P., and Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 5 (1999) 839
19. Dolstra H., Fredrix H., Maas F., et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 189 (1999) 301
20. Cavazzana-Calvo M., Fromont C., Le Deist F., et al. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin. Transplantation 50 (1990) 1
21. Montagna D., Yvon E., Calcaterra V., et al. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. Blood 93 (1999) 3550
22. Martins SL, St John LS, Champlin RE, et al. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. 2004;104:3429.
23. Wilson D.B., Wilson D.H., Schroder K., et al. Specificity and degeneracy of T cells. Mol Immunol 40 (2004) 1047
24. Amrolia P.J., Muccioli-Casadei G., Yvon E., et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 102 (2003) 2292
25. Szabolcs P., Park K.D., Marti L., et al. Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2 immunotoxin. Biol Blood Marrow Transplant 10 (2004) 772
26. Davies J.K., Koh M.B., and Lowdell M.W. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. Biol Blood Marrow Transplant 10 (2004) 259
27. Andre-Schmutz I., Le Deist F., Hacein-Bey-Abina S., et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 360 (2002) 130
28. Solomon S.R., Mielke S., Savani B.N., et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 106 (2005) 1123